| 股號 / 名稱 | 營收 | 稅後淨利 |
| JNJ 嬌生 | 832,699,438,038.82 | 6,884,793,967.8 |
| MRK 默克藥廠 | 592,911,899,560.3 | 166,120,243,023.06 |
| BMY 施貴寶 | 428,463,677,929.42 | 70,880,593,135.16 |
| NVO 諾和諾德 | 393,638,224,608.66 | 83,206,059,472.81 |
| AMGN 美國安進 | 339,813,759,410.7 | 126,680,209,007.52 |
| GILD 吉利德科學 | 272,113,285,394.0 | 79,634,116,894.22 |
| TEVA Teva Pharmaceutical Industries Limited | 135,794,364,831.56 | -18,884,006,311.68 |
| 1795 美時 | 8,808,676,000 | 642,252,000 |
| 4166 友霖 | 427,078,000 | 57,440,000 |
| 6589 台康生技 | 312,311,000 | -193,957,000 |
| 6620 漢達 | 211,951,000 | 31,632,000 |
| 6467 泰合 | 1,341,000 | -52,899,000 |
載入數據中...
和藥價與專利壓力相關的產業概念股
藥價與專利壓力概念股營收排名、龍頭是誰？
藥價與專利壓力概念股相關指標排名
藥價與專利壓力每月營收
藥價與專利壓力每股盈餘
藥價與專利壓力每股淨值
藥價與專利壓力損益表
藥價與專利壓力總資產
藥價與專利壓力負債和股東權益
藥價與專利壓力現金流量表
藥價與專利壓力利潤比率
藥價與專利壓力營業費用率拆解
藥價與專利壓力杜邦分析
藥價與專利壓力ROE / ROA
藥價與專利壓力經營週轉能力
藥價與專利壓力營運週轉天數
藥價與專利壓力現金股利發放率
藥價與專利壓力財務結構比率
藥價與專利壓力流速動比率
藥價與專利壓力利息保障倍數
藥價與專利壓力現金流量分析
藥價與專利壓力營業現金流對淨利比
藥價與專利壓力盈餘再投資比率
藥價與專利壓力月營收成長率
藥價與專利壓力營收成長率
藥價與專利壓力毛利成長率
藥價與專利壓力營業利益成長率
藥價與專利壓力稅後淨利成長率
藥價與專利壓力每股盈餘成長率
藥價與專利壓力本益比評價
藥價與專利壓力股價淨值比評價
藥價與專利壓力現金股利殖利率
藥價與專利壓力平均現金股息殖利率
藥價與專利壓力董監持股比例
藥價與專利壓力董監持股質押比例